These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37793925)

  • 1. Quantifying the mental health and economic impacts of prospective Universal Basic Income schemes among young people in the UK: a microsimulation modelling study.
    Chen T; Reed H; Parra-Mujica F; Johnson EA; Johnson M; O'Flaherty M; Collins B; Kypridemos C
    BMJ Open; 2023 Oct; 13(10):e075831. PubMed ID: 37793925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
    Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
    PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the cost of smoking to the NHS in England and the impact of declining prevalence.
    Callum C; Boyle S; Sandford A
    Health Econ Policy Law; 2011 Oct; 6(4):489-508. PubMed ID: 20735898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased use of 6-monthly gonadotropin-releasing hormone agonist therapy for prostate cancer: a capacity and cost-minimization analysis for England.
    Cornford P; Halpin C; Sassmann J; Frankcom I; Braybrook S
    J Med Econ; 2023; 26(1):208-218. PubMed ID: 36749636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis.
    Pearson-Stuttard J; Kypridemos C; Collins B; Mozaffarian D; Huang Y; Bandosz P; Capewell S; Whitsel L; Wilde P; O'Flaherty M; Micha R
    PLoS Med; 2018 Apr; 15(4):e1002551. PubMed ID: 29634725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalization costs of adult community-acquired pneumonia in England.
    Campling J; Wright HF; Hall GC; Mugwagwa T; Vyse A; Mendes D; Slack MPE; Ellsbury GF
    J Med Econ; 2022; 25(1):912-918. PubMed ID: 35726515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation.
    Thomas C; Brennan A; Goka E; Squires HY; Brenner G; Bagguley D; Buckley Woods H; Gillett M; Leaviss J; Clowes M; Heathcote L; Cooper K; Breeze P
    BMJ Open; 2020 Sep; 10(9):e037486. PubMed ID: 32912949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of a vision-based patient monitoring and management system in an acute adult and an older adult mental health hospital in England.
    Malcolm R; Shore J; Stainthorpe A; Ndebele F; Wright K
    J Med Econ; 2022; 25(1):1207-1217. PubMed ID: 36377376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic impact of early intervention in psychosis services: results from a longitudinal retrospective controlled study in England.
    Tsiachristas A; Thomas T; Leal J; Lennox BR
    BMJ Open; 2016 Oct; 6(10):e012611. PubMed ID: 27798015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What will the cardiovascular disease slowdown cost? Modelling the impact of CVD trends on dementia, disability, and economic costs in England and Wales from 2020-2029.
    Collins B; Bandosz P; Guzman-Castillo M; Pearson-Stuttard J; Stoye G; McCauley J; Ahmadi-Abhari S; Araghi M; Shipley MJ; Capewell S; French E; Brunner EJ; O'Flaherty M
    PLoS One; 2022; 17(6):e0268766. PubMed ID: 35767575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding web-based behavioural support to exercise referral schemes for inactive adults with chronic health conditions: the e-coachER RCT.
    Taylor AH; Taylor RS; Ingram WM; Anokye N; Dean S; Jolly K; Mutrie N; Lambert J; Yardley L; Greaves C; King J; McAdam C; Steele M; Price L; Streeter A; Charles N; Terry R; Webb D; Campbell J; Hughes L; Ainsworth B; Jones B; Jane B; Erwin J; Little P; Woolf A; Cavanagh C
    Health Technol Assess; 2020 Nov; 24(63):1-106. PubMed ID: 33243368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of 24/7, Digital-First, NHS Primary Care on Acute Hospital Spending: Retrospective Observational Analysis.
    Winward S; Patel T; Al-Saffar M; Noble M
    J Med Internet Res; 2021 Jul; 23(7):e24917. PubMed ID: 34292160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The health care and societal costs of inherited retinal diseases in Australia: a microsimulation modelling study.
    Schofield D; Kraindler J; Tan O; Shrestha RN; West S; Hart N; Tan L; Ma A; Grigg JR; Jamieson RV
    Med J Aust; 2023 Jul; 219(2):70-76. PubMed ID: 37301731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The personal and national costs of mental health conditions: impacts on income, taxes, government support payments due to lost labour force participation.
    Schofield DJ; Shrestha RN; Percival R; Passey ME; Callander EJ; Kelly SJ
    BMC Psychiatry; 2011 Apr; 11():72. PubMed ID: 21526993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic and health impact modelling of a whole genome sequencing-led intervention strategy for bacterial healthcare-associated infections for England and for the USA.
    Fox JM; Saunders NJ; Jerwood SH
    Microb Genom; 2023 Aug; 9(8):. PubMed ID: 37555752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users.
    O'Flaherty M; Lloyd-Williams F; Capewell S; Boland A; Maden M; Collins B; Bandosz P; Hyseni L; Kypridemos C
    Health Technol Assess; 2021 May; 25(35):1-234. PubMed ID: 34076574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study.
    Campbell HE; Kurinczuk JJ; Heazell A; Leal J; Rivero-Arias O
    BJOG; 2018 Jan; 125(2):108-117. PubMed ID: 29034559
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.